Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0003719
UniProt IDO00189
Primary gene name(s)AP4M1
Synonym gene name(s)MUARP2
Protein nameAP-4 complex subunit mu-1
Protein functionComponent of the AP-4 complex, a novel type of clathrin- or non-clathrin-associated protein coat involved in targeting proteins from the trans-Golgi network, TGN to the endosomal-lysosomal system. Plays a role in the intracellular trafficking of APP from the trans-Golgi network, TGN to endosomes, and thereby inhibits amyloidogenic processing of APP. {ECO:0000269|PubMed:11139587, ECO:0000269|PubMed:20230749}.
Subcellular locationGolgi apparatus, trans-Golgi network {ECO:0000269|PubMed:20230749}. Endosome {ECO:0000269|PubMed:20230749, ECO:0000305|Ref.4}. Note=Found in soma and dendritic shafts of neuronal cells. {ECO:0000250|UniProtKB:Q2PWT8}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: O00189
Gene Ontology
(Biological Process)
Complete annatation
Golgi to endosome transport [GO:0006895];
intracellular protein transport [GO:0006886];
vesicle-mediated transport [GO:0016192]
Gene Ontology
(Molecular Function)
Complete annatation
transporter activity [GO:0005215]
Gene Ontology
(Cellular Component)
Complete annatation
AP-type membrane coat adaptor complex [GO:0030119];
clathrin adaptor complex [GO:0030131];
cytosol [GO:0005829];
endosome lumen [GO:0031904];
extracellular exosome [GO:0070062];
Golgi trans cisterna [GO:0000138];
trans-Golgi network [GO:0005802];
trans-Golgi network membrane [GO:0032588]
Protein-protein interaction114616
Phylogenetic treeO00189
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD30.4094304795638040.2157392488864190.323512283276899
AZA vs. DISU0.1416726098682950.5799198951901660.954982272511679
AZA vs. IL7-0.2922249324011020.139605781059670.902265776835914
AZA vs. SAHA0.00300046394055540.9903307835128560.997833334941837
DISU vs. CD3-0.280677405579180.4422886850936720.573609192041814
DISU vs. IL7-0.4437284865936770.08301492415234550.381539628535551
DISU vs. SAHA-0.1361065771187490.643183625021250.890028197242995
DMSO vs. AZA-0.03466765110870180.8413388880280831
DMSO vs. CD3-0.458301589325760.1553444265564480.243777477715926
DMSO vs. DISU-0.1789116615444720.4688595054603840.895928065625011
DMSO vs. IL7-0.2495502779867440.1775806706081730.688536164973819
DMSO vs. SAHA0.03336158989045110.8890712926243990.972686978140092
HIV vs. Mock in Activation0.2261532769284940.71793880208610.999983755607037
HIV vs. Mock in Latency0.07578509092740840.656189856359710.999834320637052
IL7 vs. CD3-0.6964061546373380.03194792867377660.0765703814437645
SAHA vs. CD3-0.4299440644967360.2276671708852870.333937169804662
SAHA vs. IL70.2926907335907510.2375157939528730.478907581333012
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) unknown
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.0582448 0.974622
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
1.039 1.298 1.2 1.353 1.311
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
3L81 X-ray 1.6Å A=160-453.
4MDR X-ray 1.8Å A=160-453.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa04142 Lysosome - Homo sapiens (human)